Stock Purchase Warrant Sample Contracts

NEUROONE MEDICAL TECHNOLOGIES Corp – NEUROONE MEDICAL TECHNOLOGIES CORPORATION CAPITAL STOCK PURCHASE WARRANT (October 6th, 2017)

This Warrant is issued in connection with the Company’s private offering solely to accredited investors of up to $1,000,000 (or such higher amount as the Company’s Board of Directors shall determine) aggregate principal amount of Convertible Promissory Notes (the “Notes”) and related Warrants in accordance with, and subject to, the terms and conditions described in the Subscription Agreement, dated as of__________, _____ (the “Subscription Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to those terms in the Notes or the Subscription Agreement, as the case may be.

SolarWindow Technologies, Inc. – FORM OF SERIES S STOCK PURCHASE WARRANT (September 29th, 2017)

SolarWindow Technologies, Inc., a Nevada corporation (the “Company”), hereby certifies that [●], its permissible transferees, designees, successors and assigns (collectively, the “Holder”), for value received, is entitled to purchase from the Company at any time and from time to time commencing on the date first appearing above (the “Issuance Date”), up to and through 12:01a.m. (EST) on the date five (5) years from the Issuance Date (the “Termination Date”) up to [●] shares (each, a “Share" and collectively the “Shares”) of the Company's common stock, par value $0.001 (the “Common Stock”), at an exercise price per Share of $3.42 (the “Exercise Price”). The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof.

Greenway Technologies Inc – UMED HOLDINGS, INC. STOCK PURCHASE WARRANT Expiring October 31, 2020 (September 21st, 2017)

THIS IS TO CERTIFY that, for value received, NORMAN T. REYNOLDS (the “Holder”) is entitled at any time from the date hereof, but prior to 5:00 p.m., Fort Worth, Texas time on October 31, 2020, subject to and upon the terms and conditions contained herein, to purchase up to 4,000,000 fully paid and non-assessable shares of the common stock, par value $0.0001 per share (the “Common Stock”) of UMED HOLDINGS, INC., a Texas corporation (the “Company”) at a purchase price of $0.20 per share (the “Exercise Price”) of the Common Stock, after taking into account the restricted nature of the shares of the Common Stock as described below (such number of the shares of the Common Stock and the purchase price being subject to adjustment as provided herein). This Warrant shall be void and of no effect and all rights hereunder shall cease at 5:00 p.m., Fort Worth, Texas time on October 31, 2020, except to the extent theretofore exercised; provided that in the case of the earlier dissolution of the Com

Greenway Technologies Inc – UMED HOLDINGS, INC. STOCK PURCHASE WARRANT Expiring February 1, 2020 (September 21st, 2017)

THIS IS TO CERTIFY that, for value received, RICHARD J. HALDEN (the “Holder”) is entitled at any time from the date hereof, but prior to 5:00 p.m., Fort Worth, Texas time on February 1, 2020, subject to and upon the terms and conditions contained herein, to purchase up to 2,000,000 fully paid and non-assessable shares of the common stock, par value $0.0001 per share (the “Common Stock”) of UMED HOLDINGS, INC., a Texas corporation (the “Company”) at a purchase price of $0.45 per share (the “Exercise Price”) of the Common Stock, after taking into account the restricted nature of the shares of the Common Stock as described below (such number of the shares of the Common Stock and the purchase price being subject to adjustment as provided herein). This Warrant shall be void and of no effect and all rights hereunder shall cease at 5:00 p.m., Fort Worth, Texas time on February 1, 2020, except to the extent theretofore exercised; provided that in the case of the earlier dissolution of the Comp

Greenway Technologies Inc – UMED HOLDINGS, INC. STOCK PURCHASE WARRANT Expiring February 1, 2019 (September 21st, 2017)

THIS IS TO CERTIFY that, for value received, RICHARD J. HALDEN (the “Holder”) is entitled at any time from the date hereof, but prior to 5:00 p.m., Fort Worth, Texas time on February 1, 2019, subject to and upon the terms and conditions contained herein, to purchase up to 4,000,000 fully paid and non-assessable shares of the common stock, par value $0.0001 per share (the “Common Stock”) of UMED HOLDINGS, INC., a Texas corporation (the “Company”) at a purchase price of $0.35 per share (the “Exercise Price”) of the Common Stock, after taking into account the restricted nature of the shares of the Common Stock as described below (such number of the shares of the Common Stock and the purchase price being subject to adjustment as provided herein). This Warrant shall be void and of no effect and all rights hereunder shall cease at 5:00 p.m., Fort Worth, Texas time on February 1, 2019, except to the extent theretofore exercised; provided that in the case of the earlier dissolution of the Comp

NEUROONE MEDICAL TECHNOLOGIES Corp – NEUROONE MEDICAL TECHNOLOGIES CORPORATION CAPITAL STOCK PURCHASE WARRANT (August 23rd, 2017)

This Certified That, for value received, [_______________] (the “Holder”) is entitled to subscribe for and purchase from NeuroOne Medical Technologies Corporation, a Delaware corporation (the “Company”), at any time commencing on [DATE] and expiring on the five year anniversary (the “Warrant Exercise Term”), the Shares at the Exercise Price (each as defined in Section 1 below).

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. SERIES S STOCK PURCHASE WARRANT (July 28th, 2017)

This Warrant is being issued to Holder in connection with the Loan Agreement (the “Agreement”) entered into as of even date as this Warrant by and between the Company and Holder. Any capitalized but undefined terms used herein shall have the meaning set forth in the Agreement unless the context otherwise requires.

RenovaCare, Inc. – RENOVACARE, INC. SERIES G STOCK PURCHASE WARRANT (July 24th, 2017)

This Warrant is being issued to Holder in connection with the Loan Agreement (the “Agreement”) entered into as of even date as this Warrant by and between the Company and Holder. Any capitalized but undefined terms used herein shall have the meaning set forth in the Agreement unless the context otherwise requires.

NEUROONE MEDICAL TECHNOLOGIES Corp – NEUROONE, INC. CAPITAL STOCK PURCHASE WARRANT (July 20th, 2017)

This Warrant is issued in connection with the Company’s private offering solely to accredited investors of up to $1,500,000 (or such higher amount as the Company’s Board of Directors shall determine) aggregate principal amount of Convertible Promissory Notes (the “Notes”) and related Warrants in accordance with, and subject to, the terms and conditions described in the Subscription Agreement, dated as of November 21, 2016 (the “Subscription Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to those terms in the Notes or the Subscription Agreement, as the case may be.

NEUROONE MEDICAL TECHNOLOGIES Corp – FIRST AMENDMENT TO CAPITAL STOCK PURCHASE WARRANTS (July 20th, 2017)

This First Amendment to capital Stock Purchase Warrants (this “Amendment”) is made effective as of this 18th day of June, 2017, by and between NeuroOne, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, who are holders of the Company’s Capital Stock Purchase Warrants (each, a “Holder” and collectively, the “Holders”).

RenovaCare, Inc. – RENOVACARE, INC. SERIES F STOCK PURCHASE WARRANT (March 1st, 2017)

This Warrant is being issued to Holder in connection with the Loan Agreement (the “Agreement”) entered into as of even date as this Warrant by and between the Company and Holder. Any capitalized but undefined terms used herein shall have the meaning set forth in the Agreement unless the context otherwise requires.

Mast Therapeutics, Inc. – SAVARA INC. STOCK PURCHASE WARRANT (EXERCISABLE ONLY UPON AN EXERCISE EVENT) (February 10th, 2017)

THIS CERTIFIES that             (the “Holder”) is entitled, upon the terms and subject to the conditions set forth in this Warrant (this “Warrant”), but in any event expressly conditioned on the consummation of, but not prior to, the Exercise Event (as defined below) occurring on or prior to the Expiration Date (as defined below), but not thereafter, to subscribe for and purchase from Savara Inc., a Delaware corporation (the “Company”),             shares of Preferred Stock (as defined below), subject to adjustment as set forth in UUSection 11UU (the “Shares”). This Warrant is one of the “Warrants” (the “Bridge Warrants”) issued in connection with the issuance of a series of subordinated convertible promissory notes (collectively the “Notes” and each a “Note”) by the Company to raise interim financing initially of up to $5,000,000, with up to an additional $10,000,000, subject to approval at the discretion of the Company’s Board of Directors.

Mast Therapeutics, Inc. – SAVARA INC. STOCK PURCHASE WARRANT (February 10th, 2017)

THIS CERTIFIES that             (the “Holder”) is entitled, upon the terms and subject to the conditions hereinafter set forth, to subscribe for and purchase, from Savara Inc., a Delaware corporation (the “Company”), up to             Shares (as defined below) at an exercise price of $3.12959 per share (the “Exercise Price”). The Exercise Price and the Shares purchasable hereunder are subject to adjustment as set forth in Section 9. This Warrant may be exercised for Shares at any time on or after the date hereof and prior the earliest to occur of (i) the close of business on May 30, 2017, (ii) the date on which the first Change of Control (or the “effective time” if such a time is specified in connection with the transaction constituting such Change of Control (as defined below), or (iii) the date that is 360 days following the closing of an IPO (as defined below) ((i), (ii),or (iii) as applicable, the “Expiration Date”). The Company shall provide notice to the Holder at least ten (10)

PetroShare Corp. – STOCK PURCHASE WARRANT (February 3rd, 2017)

THIS CERTIFIES that, for value received, GVC Capital LLC, or assigns (the “Holder”), is entitled, upon the terms and subject to the conditions hereinafter set forth, at any time or from time to time on or after the date of issuance of this Warrant (the “Initial Exercise Date”) and on or prior to 5 p.m. Denver time on December 31, 2021 (the “Termination Date”) unless sooner terminated in accordance with the provisions of paragraph 17 as hereinafter described but not thereafter, to subscribe for and purchase from PetroShare Corp., a Colorado corporation (the “Company”), up to [·] shares (the “Warrant Shares”) of common stock, $0.001 par value per share of the Company (the “Common Stock”).  The purchase price of one share of Common Stock (as may be adjusted in accordance with the provisions hereof, the “Exercise Price”) under this Warrant shall be $1.50.

PetroShare Corp. – STOCK PURCHASE WARRANT (February 3rd, 2017)

THIS CERTIFIES that, for value received, [HOLDER], or assigns (the “Holder”), is entitled, upon the terms and subject to the conditions hereinafter set forth, at any time or from time to time on or after the date of issuance of this Warrant (the “Initial Exercise Date”) and on or prior to 5 p.m. Denver time on December 31, 2019 (the “Termination Date”) unless sooner terminated in accordance with the provisions of paragraph 17 as hereinafter described but not thereafter, to subscribe for and purchase from PetroShare Corp., a Colorado corporation (the “Company”), up to [·] shares (the “Warrant Shares”) of common stock, $0.001 par value per share of the Company (the “Common Stock”).  The purchase price of one share of Common Stock (as may be adjusted in accordance with the provisions hereof, the “Exercise Price”) under this Warrant shall be $3.00.

Accelerated Pharma, Inc. – ACCELERATED PHARMA, INC. Series A Preferred Stock Purchase Warrant (October 11th, 2016)

THIS CERTIFIES THAT, for value received, TALLIKUT PHARMACEUTICALS, INC. (the “Holder”), is entitled to subscribe for and purchase, at the Exercise Price (as defined below), from Accelerated Pharma, Inc., a Delaware corporation (the “Company”), shares of the Company’s Series A Convertible Preferred Stock, par value $0.00001 (the “Preferred Stock”), at any time prior to 5:00 p.m., New York time, on February 19, 2021 (the “Warrant Exercise Term”).

RenovaCare, Inc. – RENOVACARE, INC. SERIES E STOCK PURCHASE WARRANT (September 16th, 2016)

This Warrant is being issued to Holder in connection with the Loan Agreement (the “Agreement”) entered into as of even date as this Warrant by and between the Company and Holder. Any capitalized but undefined terms used herein shall have the meaning set forth in the Agreement unless the context otherwise requires.

Obalon Therapeutics Inc – OBALON THERAPEUTICS, INC. PREFERRED STOCK PURCHASE WARRANT (September 9th, 2016)

This Preferred Stock Purchase Warrant (the “Warrant”) is issued as of February 24, 2012, by Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), to [            ], or its assigns (the “Holder”). This Warrant is one of a series of Warrants containing substantially identical terms and conditions issued by the Company pursuant to the Note and Warrant Purchase Agreement dated as of February 24, 2012 by and among the Company and the purchasers described therein (the “Purchase Agreement”) with an aggregate principal amount of $1,500,000.00 (the “Notes”). Capitalized terms used but not defined herein shall have the meaning therefor set forth in the Purchase Agreement or the Notes, as applicable. This Warrant is subject to the following terms and conditions.

Players Network – STOCK PURCHASE WARRANT AGREEMENT (August 23rd, 2016)

THIS CERTIFIES THAT, for value received, Rxmm Health Pty Ltd. or its registered assigns, is entitled to purchase from Players Network, Inc. a Nevada corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2 hereof, Fifty Million (50,000,000) Common Shares to be vested as outlined in the Definitive Funding Agreement dated August 15th, 2016, between Players Network and Rxmm Health. After each tranche is vested the warrant become fully paid and exercisable for the purchase of non-assessable shares of the Company’s Common Stock, par value $0.001 per share (the “Common Stock”), and the warrants will be deemed earned and available to exercise at a price as outlined in Exhibit A Strike Price and Warrant Schedule (the “Exercise Price”). The term “Warrant Shares,” as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The term

Cti Industries Corp – STOCK PURCHASE WARRANT TO PURCHASE COMMON STOCK OF CTI INDUSTRIES CORPORATION (August 22nd, 2016)

This certifies that, for value received,                          , or his assigns, is entitled to subscribe for and purchase from CTI INDUSTRIES CORPORATION, an Illinois corporation (hereinafter called the "Company"), at a price of Seven Dollars ($7.00) per share between six (6) months and three (3) years after the date of issuance fully paid and non-assessable shares of the Company=s no par value common stock (hereinafter referred to as the ACommon Stock@).

Thar Pharmaceuticals Inc – STOCK PURCHASE WARRANT (August 19th, 2016)

For value received, Thar Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, hereby certifies that [                    ] (the “Holder”) or its permitted assign(s) is entitled to purchase from the Company, at any time or from time to time during the Exercise Period (as defined below), in whole or in part, [NUMBER EQUAL TO PRINCIPAL AMOUNT OF NOTE DIVIDED BY $11.68 ROUNDED DOWN TO NEAREST WHOLE NUMBER] shares of the Company’s Series A-1 Preferred Stock, par value $.001 per share (“Preferred Stock”), at a price per share equal to $11.68 (the “Exercise Price”). This Warrant is issued pursuant to that certain Amended and Restated Note and Warrant Purchase Agreement, dated as of August 14, 2013, by and among the Company and the Purchasers listed on Schedule A thereto (as so amended and restated, the “Agreement”). In addition to the terms and conditions of the Agreement, this Warrant is subject the following terms and conditions.

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. SERIES Q STOCK PURCHASE WARRANT (June 23rd, 2016)

SolarWindow Technologies, Inc., a Nevada corporation (the "Company"), hereby certifies that [], its permissible transferees, designees, successors and assigns (collectively, the "Holder"), for value received, is entitled to purchase from the Company at any time and from time to time commencing on the date first appearing above (the "Issuance Date"), up to and through 12:01a.m. (EST) on the date three (3) years from the Issuance Date (the "Termination Date") up to [] shares (each, a "Share" and collectively the "Shares") of the Company's common stock, par value $0.001 (the "Common Stock"), at an exercise price per Share of $3.20 (the "Exercise Price"). The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof.

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. SERIES R STOCK PURCHASE WARRANT (June 23rd, 2016)

SolarWindow Technologies, Inc., a Nevada corporation (the "Company"), hereby certifies that [], its permissible transferees, designees, successors and assigns (collectively, the "Holder"), for value received, is entitled to purchase from the Company at any time and from time to time commencing on the date first appearing above (the "Issuance Date"), up to and through 12:01a.m. (EST) on the date five (5) years from the Issuance Date (the "Termination Date") up to [] shares (each, a "Share" and collectively the "Shares") of the Company's common stock, par value $0.001 (the "Common Stock"), at an exercise price per Share of $4.00 (the "Exercise Price"). The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof.

ID Global Solutions Corp – STOCK PURCHASE WARRANT (April 25th, 2016)

THIS CERTIFIES THAT, for value received, [   ] (the “Holder”) or its registered assigns, is entitled to purchase from ID Global Solutions Corporation, a Delaware corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2 hereof, [such number of shares of common stock equal to the conversion shares] fully paid and nonassessable shares of the Company’s Common Stock, par value $.0001 per share (the “Common Stock”), at an exercise price per share equal to $0.25 (the “Exercise Price”). The term “Warrant Shares,” as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The term “Warrants” means this Warrant and the other warrants issued pursuant to that certain Securities Purchase Agreement, dated April __, 2016, by and among the Company and the Buyers listed on the execution page thereof (the “Securities Purchase Agreement”).

Vertical Computer Systems Inc – [Form of Stock Purchase Warrant] (April 14th, 2016)

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO VERTICAL COMPUTER SYSTEMS, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

Thar Pharmaceuticals Inc – STOCK PURCHASE WARRANT (April 13th, 2016)

This Warrant is issued pursuant to that certain Note and Warrant Purchase Agreement, dated as of the date hereof, by and between the Company and the Purchasers listed on Schedule A thereto (the “Note and Warrant Purchase Agreement”). In addition to the terms and conditions of the Note and Warrant Purchase Agreement, this Warrant is subject the following terms and conditions.

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. SERIES P STOCK PURCHASE WARRANT (February 24th, 2016)

This Series P Stock Purchase Warrant (this "Warrant") is issued pursuant to the Subscription Agreement between the Holder and the Company (the "Subscription Agreement"), which Subscription Agreement was executed and delivered in accordance with the terms and conditions of the Company's Offering conducted pursuant to a Private Placement Memorandum dated February 16, 2016, and is one of the Warrants being issued in connection with the issuance of the Company's securities in the Offering. Capitalized terms used herein, but not otherwise defined, shall have the meanings ascribed to such terms in the Subscription Agreement.

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. SERIES O STOCK PURCHASE WARRANT (February 24th, 2016)

This Series O Stock Purchase Warrant (this "Warrant") is issued pursuant to the Subscription Agreement between the Holder and the Company (the "Subscription Agreement"), which Subscription Agreement was executed and delivered in accordance with the terms and conditions of the Company's Offering conducted pursuant to a Private Placement Memorandum dated February 16, 2016, and is one of the Warrants being issued in connection with the issuance of the Company's securities in the Offering. Capitalized terms used herein, but not otherwise defined, shall have the meanings ascribed to such terms in the Subscription Agreement.

InterCore, Inc. – STOCK PURCHASE WARRANT (January 8th, 2016)

THIS IS TO CERTIFY that, for value received, __________, or its assigns (the “Holder”) is entitled, subject to the terms and conditions set forth herein, to purchase from InterCore, Inc., a Delaware corporation (the “Company”) up to __________ fully paid and non-assessable shares of common stock of the Company (the “Warrant Securities”) at $_____ per share, as adjusted under Section 3 (the “Exercise Price”), upon payment by cashier’s check or wire transfer of the Exercise Price for such shares of the Common Stock to the Company at the Company’s offices.

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. FORM OF SERIES N STOCK PURCHASE WARRANT (January 7th, 2016)

SolarWindow Technologies, Inc., a Nevada corporation (the "Company"), hereby certifies that Kalen Capital Corporation, its permissible transferees, designees, successors and assigns (collectively, the "Holder"), for value received, is entitled to purchase from the Company at any time and from time to time commencing on the date first appearing above (the "Issuance Date"), up to and through 12:01a.m. (EST) on the date five (5) years from the Issuance Date (the "Termination Date") up to 767,000 shares (each, a "Share" and collectively the "Shares") of the Company's common stock, par value $0.001 (the "Common Stock"), at an exercise price per Share of $3.38 (the "Exercise Price"). The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof.

COPsync, Inc. – AMENDMENT TO STOCK PURCHASE WARRANT (December 18th, 2015)

THIS AMENDMENT (“Amendment”) to that certain Stock Purchase Warrant (the “Warrant”), by and between COPsync, Inc., a Delaware corporation (the “Company”) and each of the persons that are signatories to this Amendment (“Investor”), is made as of December 15, 2015 (the “Effective Date”).

SolarWindow Technologies, Inc. – SOLARWINDOW TECHNOLOGIES, INC. FORM OF SERIES M STOCK PURCHASE WARRANT (December 11th, 2015)

SolarWindow Technologies, Inc., a Nevada corporation (the "Company"), hereby certifies that [·], its permissible transferees, designees, successors and assigns (collectively, the "Holder"), for value received, is entitled to purchase from the Company at any time and from time to time commencing on the date first appearing above (the "Issuance Date"), up to and through 12:01a.m. (EST) on the date five (5) years from the Issuance Date (the "Termination Date") up to [·] shares (each, a "Share" and collectively the "Shares") of the Company's common stock, par value $0.001 (the "Common Stock"), at an exercise price per Share of $2.34 (the "Exercise Price"). The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof.

Netlist Inc – AMENDMENT NO. 1 TO STOCK PURCHASE WARRANT (November 19th, 2015)

This AMENDMENT NO. 1 (this “Amendment”) to Stock Purchase Warrant is entered into as of November 18, 2015 by and between Netlist, Inc., a Delaware corporation (the “Company”), and Drawbridge Special Opportunities Fund LP, a Delaware limited partnership (the “Registered Holder”).  This Amendment No. 1 amends certain provisions of the Stock Purchase Warrant (Certificate No. W-2) issued by the Company to the Registered Holder as of July 18, 2013, as set forth below (the “Original Warrant”).  Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Warrant.

American CareSource Holdings, Inc. – STOCK PURCHASE WARRANT (October 22nd, 2015)

This is to Certify That, FOR VALUE RECEIVED, Mark Oman (Holder) is entitled to purchase, subject to the provisions of this Warrant, from AMERICAN CARESOURCE HOLDINGS, INC., a Delaware corporation (Company), Ninety-Nine Thousand Nine Hundred Ninety (99,990) fully paid, validly issued and nonassessable shares of common stock, par value $0.01 per share, of the Company (Common Stock) at a price One Dollar and Seventy Cents ($1.70) per share (the “Exercise Price”) at any time or from time to time during the period from the date hereof to 5:00 p.m. Eastern Standard Time, on August 12, 2020. The number of shares of Common Stock to be received upon the exercise of this Warrant and the price to be paid for each share of Common Stock may be adjusted from time to time as hereinafter set forth. The exercise price and the number of shares issuable upon exercise of this Warrant will be proportionately adjusted for stock splits, stock dividends, recapitalizations and similar transactions. The shares

American CareSource Holdings, Inc. – STOCK PURCHASE WARRANT (October 22nd, 2015)

This is to Certify That, FOR VALUE RECEIVED, John Pappajohn (Holder) is entitled to purchase, subject to the provisions of this Warrant, from AMERICAN CARESOURCE HOLDINGS, INC., a Delaware corporation (Company), One Hundred Fifty Thousand (150,000) fully paid, validly issued and nonassessable shares of common stock, par value $0.01 per share, of the Company (Common Stock) at a price of One Dollar and Seventy Cents ($1.70) per share (the “Exercise Price”) at any time or from time to time during the period from the date hereof to 5:00 p.m. Eastern Standard Time, on August 12, 2020. The number of shares of Common Stock to be received upon the exercise of this Warrant and the price to be paid for each share of Common Stock may be adjusted from time to time as hereinafter set forth. The exercise price and the number of shares issuable upon exercise of this Warrant will be proportionately adjusted for stock splits, stock dividends, recapitalizations and similar transactions. The shares of Co